SBC Medical Group Holdings Incorporated (NASDAQ: SBC) is a Industrials company (Consulting Services) with a market capitalization of $756M. The Maz Rating grades it against the other companies in its sector.
About three months ago (August 17, 2026), SBC Medical Group Holdings Incorporated had a Maz Rating of 4.62 out of 5 (A, Strong Buy), ranked against the other companies in its sector. Its strongest factor then was Financial Health (4.86), among the strongest in its sector; its weakest was Growth (2.45), below most of its sector. The other factors: Profitability 4.61 (among the strongest in its sector); Valuation 3.85 (more attractively valued than most of its sector); Momentum 2.86 (around the middle of its sector). The current rating is for members: log in to see it.
At $7.35, SBC Medical Group Holdings Incorporated trades at 14.7x trailing earnings, 4.0x sales and 2.5x book value, with an EV/EBITDA of 7.1. Over the last twelve months it generated about $190M of revenue and $51M of net income. It runs a gross margin of 72.0%, an operating margin of 39.9% and a net margin of 27.3%. It shows return on equity of 19.4%, return on invested capital of 13.5% and a free cash flow yield of 13.1%. On the balance sheet: a debt-to-equity ratio of 0.15 and a current ratio of 3.67. Over the past 52 weeks the share price ranged from $2.78 to $7.39, with a beta of 0.63.
SBC Medical Group Holdings Incorporated does not currently pay a dividend.
1 Wall Street analyst rating covers the stock: 1 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.